ARCHIVES

Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Ralph Steinman Wins Nobel Prize Three Days After His Death

October 14, 2011

In Brief: ESMO Names Annual Award Winners

October 10, 2014

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

Diet Supplements Should Be Held To Scientific Standards, Broder Tells House

August 6, 1993

In Brief: Carcinogenesis: Does The Promise Justify The Effort? Task Force Attempts To Find Out

September 30, 1977